Ukrainian infectists, using antibody detection in patients with COVID-19, will expand the possibilities of diagnosis and treatment of this disease.
This was stated in an interview with Ukrinform by an infectious disease doctor, MD, Olga Golubovskaya.
Asked about the possibility of using the blood of COVID-19 patients to treat new patients, Golubovskaya said: “In addition to plasma transfusion, which everyone is talking about, ELISA (enzyme-linked immunosorbent assay) methods open up completely different diagnostic possibilities. These are very sensitive methods that are important not only in the acute period, but also for those who are asymptomatic. After all, the number of people infected and the number of cases are different things. And the number of people infected can only be detected through such studies. “
According to Golubovskaya, “so far we have had the opportunity to test only with rapid methods, but they have completely different specificity and sensitivity, they are more likely to be tested for a self-test.”
See also: Doctor predicts that 80% of Ukrainians will be infected with a coronavirus
ELISA tests, according to the doctor, make it possible to test sick patients and will make it possible in the future to obtain specific immunoglobulins, specific antibodies strictly against this virus.
As reported by Ukrinform, by the morning of April 17 in Ukraine, 4,662 cases of COVID-19 had been recorded, of which 125 were fatal, 246 patients recovered. 501 new cases were recorded per day.
According to the materials: ukrinform.ru